FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 289

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
BOLD Nasdaq Boundless Bio, Inc. 2830
BTMD Nasdaq biote Corp. 2830
BYSI Nasdaq BeyondSpring Inc. 2830
CALC Nasdaq CalciMedica, Inc. 2830
CANF Can-Fite BioPharma Ltd. 2830
CASI Nasdaq CASI Pharmaceuticals, Inc. 2830
CATX Perspective Therapeutics, Inc. 2830
CBIO Nasdaq Crescent Biopharma, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq CDT Equity Inc. 2830
CDTX Nasdaq Cidara Therapeutics, Inc. 2830
CELZ Nasdaq Creative Medical Technology Holdings, In 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEN Nasdaq Compugen Ltd. 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CHRS Nasdaq Coherus Oncology, Inc. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLNN Nasdaq Clene Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNTA Nasdaq Centessa Pharmaceuticals plc 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COGT Nasdaq Cogent Biosciences, Inc. 2830
COLL Nasdaq Collegium Pharmaceutical, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CPRX Nasdaq Catalyst Pharmaceuticals, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CSLLY Over the counter CSL Limited 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CTXR Nasdaq Citius Pharmaceuticals, Inc. 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CVM CEL-SCI Corporation 2830
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DERM Nasdaq Journey Medical Corporation 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRTS Nasdaq Alpha Tau Medical Ltd. 2830
EDIT Nasdaq Editas Medicine, Inc. 2830
ELVN Nasdaq Enliven Therapeutics, Inc. 2830
ENGN Nasdaq enGene Holdings Inc. 2830
EOLS Nasdaq Evolus, Inc. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
EQ Nasdaq Equillium, Inc. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
Results 50 through 100 of 289